GX Genomics & Biotechnology ETF (GNOM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GNOM | ||||
| Company | GX Genomics & Biotechnology ETF | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 46.24 | ||||
| High | 46.85 | ||||
| Low | 46.17 | ||||
| Latest | 46.39 | ||||
| Change | +0.03 | ||||
| % Change | +0.07% | ||||
| Volume | 7,100 | ||||
| 20-Day Average Volume | 5,185 | ||||
| Previous Close | 46.36 | ||||
| Industry | N/A | ||||
| Has Options | Yes | ||||
| Technicals | |||||
| 20-Day Moving Average | 46.14 | ||||
| 20-Day Raw Stochastic | 64.70% | ||||
| 20-Day Relative Strength | 53.16 | ||||
| Weighted Alpha | +45.30 | ||||
| Today's Opinion | 72% Buy | ||||
| Previous Opinion | 56% Buy | ||||
| Last Month's Opinion | 8% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.14% since 05/01/26 | ||||
| Low | 45.15 on 05/05/26 | ||||
| High | 46.98 on 05/06/26 | ||||
| 1-Month | |||||
| %Chg | +3.02% since 04/08/26 | ||||
| Low | 43.65 on 04/29/26 | ||||
| High | 47.88 on 04/21/26 | ||||
| 3-Month | |||||
| %Chg | +0.56% since 02/06/26 | ||||
| Low | 41.16 on 03/30/26 | ||||
| High | 48.08 on 02/25/26 | ||||
| 6-Month | |||||
| %Chg | +8.93% since 11/07/25 | ||||
| Low | 41.16 on 03/30/26 | ||||
| High | 51.42 on 01/22/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 51,957 | ||||
| Shares Outstanding, K | 1,120 | ||||
| Annual Sales | 19,340,000 | ||||
| Annual Net Income | -72,340,000 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | 1.19 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Earnings Date | 03/19/13 | ||||
| Most Recent Dividend | 0.591 on 12/30/25 | ||||
| Next Ex-Dividends Date | 12/30/25 | ||||
| Ratios | |||||
| Price/Earnings ttm | -34.92 | ||||